Altium Capital Management LP Celldex Therapeutics, Inc. Transaction History

Altium Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $1.35 Million - $2.46 Million	-66,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $1.66 Million - $2.36 Million	-60,000 Reduced 47.62%	66,000 $2.25 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $2.11 Million - $3.32 Million	-59,000 Reduced 31.89%	126,000 $4.87 Million
Q3 2021 Nov 17, 2021	BUY	$28.95 - $55.99 $2.81 Million - $5.43 Million	97,000 Added 110.23%	185,000 $9.99 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $148,108 - $286,444	-5,116 Reduced 5.49%	88,000 $4 Million
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $996,213 - $1.7 Million	48,103 Added 106.86%	93,116 $3.11 Million
Q1 2021 May 06, 2021	SELL	$16.19 - $29.91 $3.15 Million - $5.82 Million	-194,507 Reduced 81.21%	45,013 $927,000
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $3.59 Million - $5.45 Million	239,520 New	239,520 $4.2 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.3B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.